Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
Clinical trial NCT00126620 · COMPLETED
Trial details
- NCT number
- NCT00126620
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2011-05-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.